Treatable

Efavirenz

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

Efavirenz contraindicated conditions:

Efavirenz desired effects:

  • Decreased Reverse Transcription to DNA

Efavirenz drug classes:

  • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

Efavirenz pharmacologic actions:

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors
  • Cytochrome P-450 CYP2C9 Inhibitors
  • Cytochrome P-450 CYP3A Inducers
  • Cytochrome P-450 CYP2C19 Inhibitors
  • Cytochrome P-450 CYP2B6 Inducers

Efavirenz mechanism of action:

  • Cytochrome P450 2C9 Inhibitors
  • Cytochrome P450 3A Inducers
  • Cytochrome P450 2C19 Inhibitors
  • Cytochrome P450 2B6 Inducers
  • Cytochrome P450 3A4 Inhibitors
  • Non-Nucleoside Reverse Transcriptase Inhibitors
  • treatable

Copyright © Treatable 2021
Last updated: 9/26/2021, 7:43:04 PM